The course covers the application of radioactive isotopes and radio-labeled pharmaceutics for diagnostic and therapeutic purposes. Moreover, emphasis will also be made on the immuno-targeting approaches which utilize radio-labeled monoclonal antibodies for diagnosis and treatment of neoplastic disorders.
